Cost-effectiveness of drug consumption rooms in France: a modelling study

A. COUSIEN ; C. DONADILLE ; L. BRIAND MADRID ; G. MARADAN ; M. JAUFFRET-ROUSTIDE ; L. LALANNE ; M. AURIACOMBE ; P. ROUX ; S. BOYER | 2024
Dans BMC Public Health (Vol.24, 2024) Article : Périodique

Background: People who inject drugs (PWID) experience many health problems which result in a heavy economic and public health burden. To tackle this issue, France opened two drug consumption rooms (DCRs) in Paris and Strasbourg in 2016. This stu[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial)

P. CARRIERI ; A. VILOTITCH ; S. NORDMANN ; C. LIONS ; L. MICHEL ; M. MORA ; A. MOREL ; G. MARADAN ; B. SPIRE ; P. ROUX | 2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique

Background: Patients receiving buprenorphine who are poor responders can continue to commit drug-related offences. Switching them from buprenorphine to methadone may result in reduced criminal behaviour. We compared self-reported offences and in[...]

Plus d'info

Ajouter à la sélection

Drug consumption rooms are effective to reduce at-risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study

L. LALANNE ; P. ROUX ; C. DONADILLE ; L. BRIAND MADRID ; I. CELERIER ; C. CHAUVIN ; N. HAMELIN ; C. KERVRAN ; G. MARADAN ; M. AURIACOMBE ; M. JAUFFRET-ROUSTIDE ; The COSINUS Study Group | 2024
Dans Addiction (Vol.119, n°1, January 2024) Article : Périodique

Aims: The primary aim of this study was to evaluate the impact of drug consumption rooms (DCRs) in France on injection equipment-sharing, while the secondary aims focused upon their impact on access to hepatitis C virus (HCV) testing and opioid [...]

Plus d'info

Ajouter à la sélection

Lien externe

Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER)

S. ANTWERPES ; M. COSTA ; M. COSTE ; M. BUREAU ; G. MARADAN ; C. CUTARELLA ; J. LELOUTRE ; O. RICCOBONO-SOULIER ; S. HEDOIRE ; E. FROT ; F. VERNIER ; S. VASSAS-GOYARD ; T. BARRÉ ; D. CASANOVA ; P. CARRIERI | 2022
Dans Harm Reduction Journal (Vol.19, 2022) Article : Périodique

BACKGROUND: ETHER ("Education THEérapeutique pour la Réduction des dommages en alcoologie" or Therapeutic education for alcohol-related harm reduction) is a multicentre community-based mixed-methods study, which aims to evaluate the effectivenes[...]

Plus d'info

Ajouter à la sélection

Lien externe

Gender and drug use discrimination among people who inject drugs: An intersectional approach using the COSINUS Cohort

I. ANWAR ; A. FAYE ; J. PEREIRA GONCALVES ; L. BRIAND MADRID ; G. MARADAN ; L. LALANNE ; M. JAUFFRET-ROUSTIDE ; M. AURIACOMBE ; P. ROUX | 2024
Dans International Journal of Women's Health (Vol.16, 2024) Article : Périodique

Purpose: Injection drug use is strongly associated with stigmatization by loved ones, healthcare providers, and society in general. This stigmatization can have negative consequences on the health of people who inject drugs (PWID) and limit thei[...]

Plus d'info

Ajouter à la sélection

Lien externe

Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort

P. ROUX ; M. JAUFFRET-ROUSTIDE ; C. DONADILLE ; L. BRIAND MADRID ; C. DENIS ; I. CELERIER ; C. CHAUVIN ; N. HAMELIN ; G. MARADAN ; M. P. CARRIERI ; C. PROTOPOPESCU ; L. LALANNE ; M. AURIACOMBE ; The COSINUS Study Group | 2023
Dans International Journal of Epidemiology (Vol.52, n°2, April 2023) Article : Périodique

Background: The effectiveness of drug consumption rooms (DCRs) for people who inject drugs (PWID) has been demonstrated for HIV and hepatitis C virus risk practices, and access to care for substance use disorders. However, data on other health-r[...]

Plus d'info

Ajouter à la sélection

Lien externe

A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study)

T. BARRÉ ; C. RAMIER ; S. ANTWERPES ; M. COSTA ; M. BUREAU ; G. MARADAN ; V. DI BEO ; C. CUTARELLA ; J. LELOUTRE ; O. RICCOBONO-SOULIER ; S. HEDOIRE ; E. FROT ; F. VERNIER ; S. VASSAS-GOYARD ; S. DUFORT ; C. PROTOPOPESCU ; F. MARCELLIN ; D. CASANOVA ; M. COSTE ; P. CARRIERI | 2023
Dans Drug and Alcohol Review (Vol.42, n°3, March 2023) Article : Périodique

INTRODUCTION: Alcohol use disorder (AUD) is associated with a significant disease burden in France, where alcohol use is deeply rooted in culture. However, the treatment gap is large because of several barriers, including stigmatisation and drin[...]

Plus d'info

Ajouter à la sélection

Lien externe

Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study

P. ROUX ; A. FAYE ; L. SAGAON-TEYSSIER ; C. DONADILLE ; L. BRIAND MADRID ; M. P. CARRIERI ; G. MARADAN ; M. JAUFFRET-ROUSTIDE ; L. LALANNE ; M. AURIACOMBE ; The COSINUS Study Group | 2025
Dans Drug and Alcohol Review (Vol.44, n°1, January 2025) Article : Périodique

INTRODUCTION: The co-use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectivenes[...]

Plus d'info

Ajouter à la sélection

Lien externe

Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study

P. ROUX ; S. MEZAACHE ; L. BRIAND MADRID ; M. DEBRUS ; N. KHATMI ; G. MARADAN ; C. PROTOPOPESCU ; D. ROJAS-CASTRO ; P. CARRIERI | 2018
Dans International Journal of Drug Policy (Vol.59, September 2018) Article : Périodique

Aims: In France, a non-negligible proportion of opioid-dependent individuals inject morphine sulfate. Although it has not yet been officially approved as an opioid substitution treatment (OST), some physicians can prescribe its use for people in[...]

Plus d'info

Ajouter à la sélection

Salles de consommation à moindre risque : opinion et volonté d'utilisation des personnes injectrices de substances psychoactives à Marseille, France

L. BRIAND MADRID ; C. DONADILLE ; I. CELERIER ; M. GUTOWSKI ; N. GRELLI ; G. MARADAN ; M. JAUFFRET-ROUSTIDE ; L. LALANNE ; M. AURIACOMBE ; P. ROUX ; Groupe de recherche Cosinus | 2023
Dans Revue d'Epidémiologie et de Santé Publique (Vol.71, n°1, Février 2023) Article : Périodique

FRANÇAIS : Introduction : En France, les personnes injectrices de substances psychoactives (PIS) sont une des populations les plus à risque de contracter le virus de l'hépatite C (VHC). Les salles de consommation à moindre risque (SCMR) ont mon[...]

Plus d'info

Ajouter à la sélection

Lien externe

Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach

M. COSTA ; T. BARRÉ ; M. COSTE ; I. YAYA ; C. BERENGER ; M. TANTI ; C. CUTARELLA ; M. MORA ; P. POLOMENI ; M. MAYNARD ; D. TEUMA ; M. BAZIN ; G. MARADAN ; P. ROUX ; P. M. CARRIERI | 2020
Dans BMC Public Health (Vol.20, 2020) Article : Périodique

BACKGROUND: The widespread under-screening and under-treatment of alcohol use disorder (AUD) contributes to its health and socioeconomic burden. We conducted a mixed-methods (qualitative and qualitative) study in people with alcohol use disorder[...]

Plus d'info

Ajouter à la sélection

Lien externe

Screening for tobacco and cannabis use by general practitioners: A French nationwide representative survey

T. BARRÉ ; V. DI BEO ; A. MOURAD ; P. CARRIERI ; G. MARADAN ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; P. VERGER ; F. BECK | 2024
Dans International Journal of Mental Health and Addiction (Online first 26/04/2024, 2024) Article : Périodique

Screening is a crucial step in the cascade of care for people who smoke tobacco or cannabis. In France, general practitioners (GPs) are considered a pillar of tobacco control, and under National Authority of Health guidelines, they are expected [...]

Plus d'info

Ajouter à la sélection

Lien externe

Variations in cannabis use level and correlates in opiate-users on methadone maintenance treatment: A French prospective study

A. MAYET ; C. LIONS ; P. ROUX ; M. MORA ; G. MARADAN ; A. MOREL ; L. MICHEL ; C. MARIMOUTOU ; M. P. CARRIERI | 2015
Dans Journal of Substance Abuse Treatment (Vol.58, November 2015) Article : Périodique

Introduction: Concurrent cannabis use is very frequent among opioid users on methadone maintenance treatment (MMT), which could reflect a coping strategy during MMT. The aims of this study were to describe variations in cannabis use and to explo[...]

Plus d'info

Ajouter à la sélection

Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France

P. ROUX ; D. ROJAS CASTRO ; K. NDIAYE ; L. BRIAND MADRID ; V. LAPORTE ; M. MORA ; G. MARADAN ; S. MOREL ; B. SPIRE ; P. CARRIERI | 2017
Dans Substance Abuse Treatment, Prevention, and Policy (Vol.12, n°46, 2017) Article : Périodique

Background: Injectable opioids are an interesting option for people who inject drugs (PWID) that do not respond to oral Opioid Maintenance Treatment (OMT). To date, intravenous (IV) buprenorphine - a safer drug than full-opioid agonists in terms[...]

Plus d'info

Ajouter à la sélection

Lien externe